@article{8c524570f9e34f5faa9b15f94752b683,
title = "Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies",
keywords = "alectinib, non-small-cell lung cancer, np28673, np28761, time to response, NP28673, NP28761",
author = "S. Gadgeel and A.T. Shaw and F. Barlesi and L. Crino and J.C.H. Yang and A.M. Dingemans and D.W. Kim and {de Marinis}, F. and M. Schulz and S.Y. Liu and R. Gupta and V. Smoljanovic and S.H.I. Ou",
year = "2019",
month = jan,
day = "1",
doi = "10.2147/LCTT.S209231",
language = "English",
volume = "10",
pages = "125--130",
journal = "Lung Cancer: Targets and Therapy",
issn = "1179-2728",
publisher = "Dove Medical Press Ltd",
}